Burrill & Company, San Francisco, CA, has made an investment in Boulder, CO-based Efficas, an early stage biotechnology company that discovers, and through partnerships, develops and markets natural pet products and cosmeceuticals. Burrill & Company’s Nutraceuticals Capital Fund LP was a seed investor in Efficas, along with Prolog Ventures, St. Louis, MO. The seed investors were joined in this Series A Round of financing by Great Spirit Ventures LLC, Grand Rapids, MI. Burrill’s Nutraceuticals Capital Fund LP invested $2.3 million of the $5 million round.